|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 403/04 | (2006.01) |
| C07D 403/14 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 17/14 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3571192 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18701296.8 |
| Date of filing the European patent application | 2018-01-16 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-30 |
| (46) | Date of publication of the claims translation | 2023-02-27 |
| (86) | Number | PCT/EP2018/051038 |
| Date | 2018-01-16 |
| (87) | Number | WO 2018/134213 |
| Date | 2018-07-26 |
| (30) | Number | Date | Country code |
| 201762447057 P | 2017-01-17 | US |
| (72) |
NILSSON, Karl, Magnus , SE
ÅSTRAND, Annika, Birgitta, Margareta , SE
BERGGREN, Anna, Ingrid, Kristina , SE
JOHANSSON, Johan, R. , SE
LEPISTÖ, Matti, Juhani , SE
KAWATKAR, Sameer, Pralhad , US
SU, Qibin , US
KETTLE, Jason, Grant , GB
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | JAK1 atžvilgiu selektyvūs inhibitoriai |
| JAK1 SELECTIVE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 8 | 185.00 EUR |
| 2026-01-16 |